A longevity biotech company combining physics, large-scale human health data, and machine learning to find drug targets for age-related disease.
Gero
Released June 20, 2025
Structure-free ligand generation conditioned on a protein sequence alone, using masked diffusion over SMILES trained on 1.2M BindingDB active pairs.